发育迟缓儿童 Delirium 评估和药物管理的差异:一个回顾性病例对照研究
Amanda R Kolmar1, Anneliese M Paton1, Michael A Kramer1
1Department of Pediatrics, Division of Critical Care, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Journal of intensive care medicine
|August 11, 2023
概括
发育迟缓 (DD) 的儿童在儿科重症监护室 (PICU) 显示出更高的妄想分数和不同的药物管理. 这凸显了对这个弱势群体的护理方面的潜在差异.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 神经发育障碍 神经发育障碍
- 药理学 药理学 是一个学科.
背景情况:
- 儿科重症监护室 (PICU) 的 Delirium 与不良结果有关.
- 康奈尔儿童痴呆症评估 (CAPD) 是一种查工具,对发育迟缓 (DD) 的儿童具有潜在的特异性限制.
研究的目的:
- 为了比较儿科重症监护室 (ICU) 患有和没有发育迟缓 (DD) 患者的 Delirium 评分和药物管理.
- 调查神经类型 (NT) 和DD儿科患者之间CAPD得分和抗精神病治疗决策的差异.
主要方法:
- 对接受治疗ICU痴呆症抗精神病药物的呼吸衰竭儿科患者进行了回顾性病例对照研究.
- 使用非参数统计数据,比较DD和NT组之间的人口统计数据,CAPD得分,药物选择,剂量和退院后的继续治疗.
主要成果:
- 与神经类型 (NT) 患者相比,发育迟缓 (DD) 患者在入院和治疗开始时表现出更高的中位数CAPD得分.
- 提供者更频繁地增加了抗精神病剂量,并释放了更多服用新抗精神病药物的DD患者.
- 群体之间在人口统计,停留时间,药物选择或初始剂量方面没有发现显著差异.
结论:
- 儿科重症监护室 (ICU) 的妄想查和管理对于发育迟缓 (DD) 的儿童有所不同.
- 医疗保健提供者应认识到DD患者基线CAPD得分升高,并仔细考虑抗精神病剂量升级.
- 需要进一步的研究,以澄清长期使用抗精神病药物对DD患者退院后的影响,并解决潜在的护理差异.
相关概念视频
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Attention-Deficit/Hyperactivity Disorder
131
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
131
Psychosis: Goals of Pharmacotherapy
166
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
166
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
197
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
197
Intellectual Disability
117
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
117
Drug Therapy
69
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
69


